An update on the management and control of Leprosy in Cuba will be released January 28 and 29 during an online workshop with prestiged dermatologists.
Leprosy: Topic of Cuban Online Scientific Workshop
Cuba reports 349 new cases of COVID-19, 277 medical discharges and five deaths
Cuba studied 10, 931 samples to detect COVID 19, resulting in 349 new cases. There are accumulated 1, 724, 741 samples carried and 19, 122 positive (1.11%).
Antigen test applied in Havana to suspected cases of COVID-19
Since Monday night, an antigen test began to be applied in polyclinics and hospitals of the capital to patients with symptoms suggestive of COVID-19.
Cuban province develops antigen test validation to detect coronavirus
A novel antigen test that would allow the early identification of those infected with the SARS CoV-2 coronavirus is in the validation process in Matanzas(west Cuba), according to what was revealed during a meeting of the Provincial Defense Council (CDP).
Cuba reports 330 new cases of COVID-19, 417 medical discharges and two deaths
Cuba studied for COVID-19, 12, 676 new samples, resulting 330 positive ones. The country accumulates 1, 713, 810 of samples carried out and 18, 773 positive (1,09%).
Cuban specialists explain health sequelae from COVID-19
Fatigue, psychological and pulmonary alterations, compatible with chronic renal damage and a persistent inflammatory response are some of the sequels caused by COVID-19, explained Daniel González Rubio, specialist in Internal Medicine at the Pedro Kourí Institute of Tropical Medicine (IPK).
Cuba concludes short cycle of trial in two of its anti-COVID 19 vaccine candidates
The clinical trials of the two vaccine candidates developed in the Center for Genetic Engineering and Biotechnology (CIGB) of Cuba concluded the short cycle of its phase I.
Cuba reports 292 new cases of COVID-19, 254 discharges and three deaths
Cuba studied 11,387 samples for COVID-19, with 292 positive tests. The country accumulates 1 ,701, 134 samples made and 18, 443 positive ones (1.8%).
Cuba begins second phase of Soberana 02 clinical trial in Havana
The vaccine candidate Soberana 02, developed by the Finlay Institute of Vaccines, started today the second stage of phase two of the clinical trials in the municipality of Plaza de la Revolución in Havana.
Cuban health minister acknowledges scientists' commitment to the people
Cuban minister of public health, Jose Angel Portal Miranda, said today that during the SARS-CoV-2 pandemic, Cuban scientists have taken great challenges to demonstrate their commitment to the health of the people, as well as the human and professional quality, modesty and selflessness that distinguish them.
Cuba reports 547 new cases of COVID-19, 243 medical discharges and two deaths
Cuba studied 14, 550 samples for COVID 19, detecting 547 new cases. The conuntry has studied a total of 1, 663, 559 samples, with 17, 096 positive (1.02%).
Cuban biotechnology progresses in tackling COVID-19 pandemic
The use of therapeutic drugs as part of the sanitary protocols of the Ministry of Public Health (MINSAP by its Spanish acronym) makes possible, to a great extent, the high rates of COVID-19 recoveries in Cuba, in spite of the current complex epidemiological situation.
Cuban scientists develop lung ventilators to assist patients in ICU
A multidisciplinary team of specialists belonging to the Cuban Neuroscience Center (CNEURO) is developing pulmonary ventilators in the country, so that patients who need them can have access to this means of medical assistance.
Cuba reports 505 new cases of COVID-19, 221 medical discharges and two deaths
Cuba studied 14, 579 samples of COVID 19, detecting 505 new cases. There are accumulated 1, 649, 009 samples carried out and 16, 549 positive (1.00%).
Cuba prepares new vaccine candidates to face possible mutations of COVID
The Center for Genetic Engineering and Biotechnology (CIGB) is developing new vaccine candidates more resistant to possible SARS-CoV-2 mutations, which cause COVID-19, announced in this capital the Doctor in Biological Sciences Gerardo Guillén Nieto, Director of Biomedical Research at that institution.